Abstract: The present invention describes a formulation comprising: (A) at least one surfactant; and (B) an anti-microbial composition that comprises (i) an anti-microbial agent with surfactant properties; (ii) a hydrophobic material and (iii) a polar solvent.

Abstract: The present invention describes a formulation comprising: (A) at least one surfactant; and (B) an anti-microbial composition that comprises (i) an anti-microbial agent with surfactant properties; (ii) a hydrophobic material and (iii) a polar solvent.

Abstract: A thermoplastic composition is prepared by melt blending a poly(arylene ether) and an other resin, where the poly(arylene ether) has a particular molecular weight distribution. The thermoplastic composition exhibits significantly increased melt flow compared to compositions containing poly(arylene ether)s with similar intrinsic viscosities but different molecular weight distributions. The increased melt flow facilitates preparation of the thermoplastic composition and subsequent article fabrication procedures.

Abstract: Embodiments of the invention provide a home communications device. The home communications device is connected to an external network comprising external devices. The home communications device comprises a plurality of interfaces for connecting a plurality of internal devices to form one or more internal networks. The home communications device further comprises a communication manager configured to enable communication among one or more of the internal devices and the external devices, wherein one or more of the internal devices operate on separate or similar communication protocols.

Abstract: The invention relates to C9orf46 homolog, a novel murine membrane protein, and its orthologs in human, mouse and all other species, termed Plg-RKT, or analogs, thereof and the isolation method. The function of this molecule is to bind to plasminogen, plasminogen fragments such as angiostatin1 and other plasminongen fragments having angiostatic activity, tissue plasminogen activator and Lipoprotein(a). Plasminogen receptors function to modulate cell surface proteolysis and physiological and pathophysiological processes requiring cell migration, including, but not limited to, cell migration during inflammation, tissue remodeling, wound healing, tumor cell invasion and metastasis, skeletal myogenesis, neurite outgrowth. Plasminogen receptors also modulate apoptosis and cell death.

Abstract: The present invention describes a formulation comprising: (A) at least one surfactant; and (B) an anti-microbial composition that comprises (i) an anti-microbial agent with surfactant properties; (ii) a hydrophobic material and (iii) a polar solvent.

Abstract: Source and drain extension regions are selectively removed by a dopant concentration dependent etch or a doping type dependent etch, and an embedded stress-generating material such as SiGe alloy or a Si:C alloy in the source and drain extension regions is grown on a semiconductor substrate. The embedded stress-generating material may be grown only in the source and drain extension regions, or in the source and drain extension regions and in deep source and drain regions. In one embodiment, an etch process that removes doped semiconductor regions of one conductivity type selective to doped semiconductor regions of another conductivity type may be employed. In another embodiment, a dopant concentration dependent etch process that removes doped semiconductor regions irrespective of the conductivity type selective to undoped semiconductor regions may be employed.

Abstract: An approach for providing compression of a database table that uses a compiled table algorithm (CTA) that provides leverage. Data within any given column in adjacent rows is often the same as or closely related to its neighbors. Rather than storing data in each column of each row as a specific integer, floating point, or character data value, a field reconstruction instruction is stored that when executed by a decompression engine can reconstruct the data value. The field reconstruction instruction may be bit granular and may depend upon past history given that the data compression engine may preserve state as row data is streamed off a storage device.

Abstract: The disclosed subject matter relates to a method of simultaneously identifying and determining the levels of expression of cysteine-containing proteins in normal and perturbed cells, a method for determining peptide expression levels between a first biological sample and a second biological sample, and a method for quantitative proteomic analysis of two or more peptide populations, and compounds and reagents related thereto.

Abstract: The present invention is directed to preventing the consequences of the misfolding of proteins, such as those associated with protein folding diseases. Provided are methods of treatment that involve administering an agent that decreases the level of the heat shock protein ATPase Aha1 and/or related molecules with similar function. Such methods can result in the rescue of folding, trafficking, and function of proteins with suboptimal folding kinetics.

Abstract: A composition for inhibiting the growth of microorganisms on non-cellulosic fibres having a moisture regain of ?5%, comprising; 1) 1 to 50 wt % of at least a self-crosslinkable resin: ii) 0.25 to 20 wt % of at least a catalyst; iii) 0.1 to 4 wt % of at least an antimicrobial active agent, reactive with the resin; iv) 98.65 to 26 wt % of water; wherein i)+ii)+iii)+iv)=100%.

Abstract: A resin composition includes a poly(arylene ether) and a pH sensitive compound capable of providing a color change when the pH sensitive compound is at least partially extracted from the resin composition and is added to a basic or acidic solution.

Abstract: A poly(arylene ether)-containing resin composition or article may be authenticated by a method that includes at least partially extracting a pH sensitive compound from the resin composition or the article with a solvent, wherein the resin composition or the article includes a poly(arylene ether) and the pH sensitive compound; mixing the solvent having the extracted pH sensitive compound with an acidic solution or a basic solution to form an observation mixture; and observing the observation mixture to determine if a predetermined color change occurred in the observation mixture.

Abstract: The present invention is directed toward a safety belt web adjuster that incorporates a sliding middle horizontal member around which the lower section of webbing is looped. This allows the webbing section to be trapped between two bars, one sliding and one fixed. The web adjuster of the present invention also allows for relatively easy adjustment of safety belt tension by moving the web adjuster through approximately 90 degrees of motion, thereby removing the bearing force on the webbing previously supplied by the fixed member, allowing the slack in the safety belt to be easily adjusted.

Abstract: The present invention relates to a method of simultaneously identifying and determining the levels of expression of cysteine-containing proteins in normal and perturbed cells, a method for proteomic analysis, a process for preparing fusion proteins, and compounds and reagents related thereto.

Abstract: The present application provides systems and/or methods for accessing a portion of a mass-fragment spectrum, constructing a vector that is responsive to an intensity-balance of the spectrum, and selecting the spectrum responsive to the vector.

Abstract: Flow probe designs that are relatively atraumatic to blood vessels and therefore are suitable for chronic implantation.

Abstract: The present invention relates to a method of simultaneously identifying and determining the levels of expression of cysteine-containing proteins in normal and perturbed cells, a method for proteomic analysis, a process for preparing fusion proteins, and compounds of Formula II and III: (II) Acyl-NH—X-[Epitope Tag Site]A-Y-[Protease Cleavage Site]-Z-Link (III) Acyl-NH—X-alk-O-Ph-CH2—Z-Link and reagents related thereto.

Abstract: Disclosed are compositions and methods for preventing, inhibiting, reducing and treating conditions and diseases associated with abnormal bone resorption in mammals, including for example osteoporosis. Embodiments of compositions of the invention comprise a pharmaceutically effective amount of alendronate and vitamin D3 suitable for once-weekly dosing. Compositions and methods of the invention provide vitamin D nutrition during bisphosphonate treatment to facilitate normal bone formation and mineralization while minimizing the occurrence of or potential for the complications associated with vitamin D insufficiency, such as hypocalcaemia and osteomalacia. Also disclosed are methods for manufacturing compositions of the present invention, for measuring stability and degradation of those compositions, and for measuring blood plasma levels of vitamin D.

Abstract: A services provision system provides information services over one or more communications networks and has a software infrastructure divided into domains. Each domain has an intelligent software agent and this community of agents sits in a computing environment represented in each domain by a DPE kernel. The community of agents co-operates to provide service and service management functionality to user. At least one of the agents is reconfigurable to change the functionality the system makes available. Reconfigurability is based on the use of a plurality of reusable software modules, the agent reconfiguring by selecting a new combination of modules. The software modules themselves incorporate rules, or policies, which determine process steps offered by the modules at run-time. These policies are external to the modules and may be loaded at run-time, allowing dynamic modification to functionality of the system.